WHO SMART Guidelines - Example Workshop IG
0.1.0 - ci-build
WHO SMART Guidelines - Example Workshop IG, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/brynrhodes/smart-workshop/ and changes regularly. See the Directory of published versions
| Official URL: http://smart.who.int/example-workshop/PlanDefinition/IMMZD2DTMeaslesOT | Version: 0.1.0 | |||
| Draft as of 2024-12-02 | Computable Name: IMMZD2DTMeaslesOT | |||
If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination
Generated Narrative: PlanDefinition IMMZD2DTMeaslesOT
CQF Knowledge capability: computable
url: PlanDefinition IMMZ.D2.DT.Measles Ongoing Transmission
version: 0.1.0
name: IMMZD2DTMeaslesOT
title: IMMZ.D2.DT.Measles Ongoing Transmission
type: ECA Rule
status: Draft
experimental: true
date: 2024-12-02 20:41:15+0000
publisher: WHO
contact: WHO: http://who.int
description:
If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination
| Type | Citation |
| Citation | WHO recommendations for routine immunization - summary tables (March 2023) |
library: IMMZD2DTMeaslesOTLogic
action
title: Immunize patient for Measles
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Measles Routine Immunization Schedule Incomplete action
CPG Rationale Extension:
In countries with ongoing transmission in which the risk of measles mortality remains high, MCV1 should be given at age 9 months.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine.
title: Provide primary series measles vaccination (MCV1)
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier No Primary Series Doses Administered action
title: Client Age Less Than 9 Months
description: Should not vaccinate client as client's age is less than 9 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV1.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Client Age Less Than 9 Months action
title: Last Live Vaccine Administered Within 4 Weeks
description: Should not vaccinate client for MCV1 as live vaccine was administered in the last 4 weeks. Check for any vaccines due and inform the caregiver of when to come back for MCV1.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Last Live Vaccine Administered Within 4 Weeks action
title: Provide Measles Vaccine
description: Should vaccinate client for MCV1 as no measles doses were administered, client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Client Is Due For MCV1 definition: IMMZ.D2.DT.Measles.MR
dynamicValue
path: dispenseRequest.validityPeriod.start
Expressions
Description Language Expression Due date of the dose text/cql-identifier MCV1 Schedule Date dynamicValue
path: dispenseRequest.validityPeriod.end
Expressions
Description Language Expression Expiration date for MCV dose text/cql-identifier MCV1 Expiration Date action
CPG Rationale Extension:
In countries with ongoing transmission in which the risk of measles mortality remains high, MCV2 should be given between 15-18 months. The minimum interval between MCV1 and MCV2 is 4 weeks.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine.
title: Provide primary series measles vaccination (MCV2)
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier One Primary Series Dose Administered action
title: Client Age Less Than 15 Months
description: Should not vaccinate client for MCV2 as client's age is less than 15 months. Check for any vaccines due, and inform the caregiver of when to come back for MCV2.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Client Age Less Than 15 Months action
title: Last Live Vaccine Administered Within 4 Weeks
description: Should not vaccinate client for MCV2 as live vaccine was administered in the last 4 weeks. Check for any vaccines due, and inform the caregiver of when to come back for MCV2.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Last Live Vaccine Administered Within 4 Weeks action
title: Provide Measles Vaccine
description: Should vaccinate client for MCV2 as client is within appropriate age range and no live vaccine administered in the last 4 weeks. Check for contraindications.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Client Is Due For MCV2 definition: IMMZ.D2.DT.Measles.MR
dynamicValue
path: dispenseRequest.validityPeriod.start
Expressions
Description Language Expression Due date of the dose text/cql-identifier MCV2 Schedule Date dynamicValue
path: dispenseRequest.validityPeriod.end
Expressions
Description Language Expression Expiration date for MCV dose text/cql-identifier MCV2 Expiration Date action
CPG Rationale Extension:
An additional dose of MCV should be administered to HIV-infected children receiving HAART following immune reconstitution. If CD4+ T lymphocyte counts are monitored, an additional dose of MCV should be administered when immune reconstitution has been achieved, e.g. when the CD4+ T lymphocyte count reaches 20–25%. Where CD4+ T lymphocyte monitoring is not available, children should receive an additional dose of MCV 6–12 months after initiation of HAART.
title: Measles primary series is complete
description: Measles primary series is complete. Two measles primary series doses were administered. Check if a measles supplementary dose is appropriate for the client.
condition
kind: Applicability
Expressions
Language Expression text/cql-identifier Two Primary Series Doses Administered